Physician profile
Matthew Mcgee
NPI 1811982804
$404.61
in general payments reported to CMS, 2019-2025
13 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.36 · 2022: $34.94 · 2023: $105 · 2024: $67.27 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $110.55 | 2025 | Tremfya, Rybrevant |
| Takeda Pharmaceuticals U.S.A., INC. | $53.61 | 2023-2025 | Glassia, Entyvio |
| United Therapeutics Corporation | $51.86 | 2024-2025 | Tyvaso, Tyvaso |
| Solventum Corporation | $27.76 | 2025 | V.A.C.Ulta |
| Phathom Pharmaceuticals, INC. | $25.62 | 2024 | Voquezna |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.39 | 2022 | |
| Genzyme Corporation | $19.95 | 2024 | |
| Qol Medical, LLC | $19.31 | 2023 | Sucraid |
| Exact Sciences Corporation | $19.08 | 2023 | Cologuard Collection Kit |
| Abbvie INC. | $14.61 | 2023 | |
| Scpharmaceuticals INC. | $13.96 | 2023 | |
| Janssen Pharmaceuticals, INC | $13.55 | 2022 | |
| Medicomp INC | $13.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.